ondasdechoque.org
PT-BR

Laser versus shockwaves for myofascial pain · Randomized trial · 2024

Does shockwave or laser ease neck and upper-back muscle pain more?

In this trial, three shockwave sessions plus home exercises lowered neck and upper-back pain from about 7 to about 4 out of 10 a month after treatment. People who had laser with the same exercises improved by a similar amount.

Both helped
people with long-lasting neck or upper-back muscle pain
46
shockwave sessions, 5–8 days apart
3
month of follow-up after treatment
1

Good to know: Everyone did the same home exercises.

Özyiğit E, Erdal A Archives of Basic and Clinical Research, 2024 · Read the paper ↗

What happened

Neck and upper-back pain

0–10 pain scale · start, end of treatment and one month later

Shockwave + exercisesLaser + exercises

With shockwave, pain fell from about 7 to 5 by the end of treatment and to about 4 a month later. With laser it went from about 7 to about 3.
Show the numbers
GroupStartEnd of treatment1 month later
Shockwave + exercises7.15.23.9
Laser + exercises6.84.33.1

The treatment

Shockwave + exercises

Shockwave, 3 sessions

ShockwavesThe paper doesn’t say whether radial or focused
Sessions
3
Pulses
2,000 per session · aimed at the two most tender points
Strength
2.0bar (10–15 pulses per second)
Numbing
Not mentioned
Device
BTL-5000 SWT compressor POWER
Everyone also got
Home posture, range-of-motion and stretching exercises, 3 sets of 10 daily for 2 months

Compared with: Laser (15 sessions over three weeks) with the same home exercises

Settings are what each study used, not a prescription.

Who took part

46 people with neck or upper-back muscle pain for at least three months and trigger points in the trapezius or back muscles; average age 35. People with fibromyalgia were excluded.

Side effects

The study does not report side effects.

All the numbers and the full appraisal
FROM THE FULL PAPER

The results, in numbers.

Patients with at least three months of neck/dorsal myofascial symptoms, diagnosed by Travell and Simons criteria, with trapezius or paraspinal trigger points; 20 analyzed per treatment. Mean age was 35.3 years. Fibromyalgia and severe cervical disc disease were excluded.

Laser plus exercise20analyzed

46 randomized overall; six excluded for missing assessment, arm-specific allocation and attrition not reported; 20 analyzed per arm.

ESWT plus exercise20analyzed

46 randomized overall; six excluded for missing assessment, arm-specific allocation and attrition not reported; 20 analyzed per arm.

Visual Analogue Scale4 reported outcomes
01
Immediately after treatment

Pain intensity

Visual Analogue Scale Points

BaselineFollow-up
Laser plus exercise
4.3
ESWT plus exercise
5.2
010 Points
means
GroupnBaselineFollow-up
Laser plus exercise206.8 (SD 1.3)4.3 (SD 1.5)
ESWT plus exercise207.1 (SD 1.9)5.2 (SD 1.9)

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

REPORTED COMPARISON TESTp = 0.314

Laser versus ESWT change

Mann–Whitney U test of changes

No statistically significant difference in change between treatments.

Analysis details and source

Endpoint means from Table 2; p value compares changes in Table 3, not raw endpoints. Missing BDI SD is printed incompletely and remains null.

02
Immediately after treatment

Pain intensity

Visual Analogue Scale Points

means
GroupnBaselineReported change
Laser plus exercise20—2.4 (SD 1.7)
ESWT plus exercise20—1.9 (SD 1.4)

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

REPORTED COMPARISON TESTp = 0.314

Laser versus ESWT

Mann–Whitney U

Source-reported improvement magnitude; no superior treatment identified.

Analysis details and source

Table 3 uses positive magnitudes for pain/depression reductions and pressure/SF-36 increases; values are not reconstructed from rounded means.

03
One month after treatment

Pain intensity

Visual Analogue Scale Points

BaselineFollow-up
Laser plus exercise
3.1
ESWT plus exercise
3.9
010 Points
means
GroupnBaselineFollow-up
Laser plus exercise206.8 (SD 1.3)3.1 (SD 2)
ESWT plus exercise207.1 (SD 1.9)3.9 (SD 2.6)

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

REPORTED COMPARISON TESTp = 0.512

Laser versus ESWT change

Mann–Whitney U test of changes

No statistically significant difference in change between treatments.

Analysis details and source

Endpoint means from Table 2; p value compares changes in Table 3, not raw endpoints. Missing BDI SD is printed incompletely and remains null.

04
One month after treatment

Pain intensity

Visual Analogue Scale Points

means
GroupnBaselineReported change
Laser plus exercise20—3.7 (SD 2.2)
ESWT plus exercise20—3.2 (SD 1.9)

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

REPORTED COMPARISON TESTp = 0.512

Laser versus ESWT

Mann–Whitney U

Source-reported improvement magnitude; no superior treatment identified.

Analysis details and source

Table 3 uses positive magnitudes for pain/depression reductions and pressure/SF-36 increases; values are not reconstructed from rounded means.

Algometer4 reported outcomes
05
Immediately after treatment

Pressure pain threshold

Algometer kg

means
GroupnBaselineFollow-up
Laser plus exercise202.5 (SD 1)3 (SD 1.2)
ESWT plus exercise202.1 (SD 0.9)3 (SD 1.2)

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

REPORTED COMPARISON TESTp = 0.127

Laser versus ESWT change

Mann–Whitney U test of changes

No statistically significant difference in change between treatments.

Analysis details and source

Endpoint means from Table 2; p value compares changes in Table 3, not raw endpoints. Missing BDI SD is printed incompletely and remains null.

06
Immediately after treatment

Pressure pain threshold

Algometer kg

means
GroupnBaselineReported change
Laser plus exercise20—0.4 (SD 0.8)
ESWT plus exercise20—0.8 (SD 0.9)

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

REPORTED COMPARISON TESTp = 0.127

Laser versus ESWT

Mann–Whitney U

Source-reported improvement magnitude; no superior treatment identified.

Analysis details and source

Table 3 uses positive magnitudes for pain/depression reductions and pressure/SF-36 increases; values are not reconstructed from rounded means.

07
One month after treatment

Pressure pain threshold

Algometer kg

means
GroupnBaselineFollow-up
Laser plus exercise202.5 (SD 1)3.7 (SD 1.1)
ESWT plus exercise202.1 (SD 0.9)3.5 (SD 1.3)

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

REPORTED COMPARISON TESTp = 0.114

Laser versus ESWT change

Mann–Whitney U test of changes

No statistically significant difference in change between treatments.

Analysis details and source

Endpoint means from Table 2; p value compares changes in Table 3, not raw endpoints. Missing BDI SD is printed incompletely and remains null.

08
One month after treatment

Pressure pain threshold

Algometer kg

means
GroupnBaselineReported change
Laser plus exercise20—1.1 (SD 1.2)
ESWT plus exercise20—1.4 (SD 1)

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

REPORTED COMPARISON TESTp = 0.114

Laser versus ESWT

Mann–Whitney U

Source-reported improvement magnitude; no superior treatment identified.

Analysis details and source

Table 3 uses positive magnitudes for pain/depression reductions and pressure/SF-36 increases; values are not reconstructed from rounded means.

Beck Depression Inventory4 reported outcomes
09
Immediately after treatment

Depressive symptoms

Beck Depression Inventory Points

means
GroupnBaselineFollow-up
Laser plus exercise2018.4 (SD 10.8)16.3 (SD 8.9)
ESWT plus exercise2013.6 (SD 7.7)11.3

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

REPORTED COMPARISON TESTp = 0.779

Laser versus ESWT change

Mann–Whitney U test of changes

No statistically significant difference in change between treatments.

Analysis details and source

Endpoint means from Table 2; p value compares changes in Table 3, not raw endpoints. Missing BDI SD is printed incompletely and remains null.

10
Immediately after treatment

Depressive symptoms

Beck Depression Inventory Points

means
GroupnBaselineReported change
Laser plus exercise20—2.1 (SD 3.5)
ESWT plus exercise20—2.3 (SD 3.2)

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

REPORTED COMPARISON TESTp = 0.779

Laser versus ESWT

Mann–Whitney U

Source-reported improvement magnitude; no superior treatment identified.

Analysis details and source

Table 3 uses positive magnitudes for pain/depression reductions and pressure/SF-36 increases; values are not reconstructed from rounded means.

11
One month after treatment

Depressive symptoms

Beck Depression Inventory Points

means
GroupnBaselineFollow-up
Laser plus exercise2018.4 (SD 10.8)15.5 (SD 8.3)
ESWT plus exercise2013.6 (SD 7.7)11.6 (SD 7.4)

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

REPORTED COMPARISON TESTp = 0.640

Laser versus ESWT change

Mann–Whitney U test of changes

No statistically significant difference in change between treatments.

Analysis details and source

Endpoint means from Table 2; p value compares changes in Table 3, not raw endpoints. Missing BDI SD is printed incompletely and remains null.

12
One month after treatment

Depressive symptoms

Beck Depression Inventory Points

means
GroupnBaselineReported change
Laser plus exercise20—3 (SD 4.8)
ESWT plus exercise20—2 (SD 3)

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

REPORTED COMPARISON TESTp = 0.640

Laser versus ESWT

Mann–Whitney U

Source-reported improvement magnitude; no superior treatment identified.

Analysis details and source

Table 3 uses positive magnitudes for pain/depression reductions and pressure/SF-36 increases; values are not reconstructed from rounded means.

SF-36 physical component4 reported outcomes
13
Immediately after treatment

Physical health

SF-36 physical component Points

means
GroupnBaselineFollow-up
Laser plus exercise2038.2 (SD 7.9)40.7 (SD 8.7)
ESWT plus exercise2036.7 (SD 5.8)41.2 (SD 6.7)

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

REPORTED COMPARISON TESTp = 0.221

Laser versus ESWT change

Mann–Whitney U test of changes

No statistically significant difference in change between treatments.

Analysis details and source

Endpoint means from Table 2; p value compares changes in Table 3, not raw endpoints. Missing BDI SD is printed incompletely and remains null.

14
Immediately after treatment

Physical health

SF-36 physical component Points

means
GroupnBaselineReported change
Laser plus exercise20—2.5 (SD 4.3)
ESWT plus exercise20—4.5 (SD 4.9)

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

REPORTED COMPARISON TESTp = 0.221

Laser versus ESWT

Mann–Whitney U

Source-reported improvement magnitude; no superior treatment identified.

Analysis details and source

Table 3 uses positive magnitudes for pain/depression reductions and pressure/SF-36 increases; values are not reconstructed from rounded means.

15
One month after treatment

Physical health

SF-36 physical component Points

means
GroupnBaselineFollow-up
Laser plus exercise2038.2 (SD 7.9)42.3 (SD 8)
ESWT plus exercise2036.7 (SD 5.8)43.6 (SD 6)

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

REPORTED COMPARISON TESTp = 0.336

Laser versus ESWT change

Mann–Whitney U test of changes

No statistically significant difference in change between treatments.

Analysis details and source

Endpoint means from Table 2; p value compares changes in Table 3, not raw endpoints. Missing BDI SD is printed incompletely and remains null.

16
One month after treatment

Physical health

SF-36 physical component Points

means
GroupnBaselineReported change
Laser plus exercise20—4.2 (SD 4.6)
ESWT plus exercise20—6.9 (SD 7.2)

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

REPORTED COMPARISON TESTp = 0.336

Laser versus ESWT

Mann–Whitney U

Source-reported improvement magnitude; no superior treatment identified.

Analysis details and source

Table 3 uses positive magnitudes for pain/depression reductions and pressure/SF-36 increases; values are not reconstructed from rounded means.

SF-36 mental component4 reported outcomes
17
Immediately after treatment

Mental health

SF-36 mental component Points

means
GroupnBaselineFollow-up
Laser plus exercise2038.7 (SD 9.1)41.9 (SD 7.7)
ESWT plus exercise2043.5 (SD 12.4)46.7 (SD 9.5)

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

REPORTED COMPARISON TESTp = 0.414

Laser versus ESWT change

Mann–Whitney U test of changes

No statistically significant difference in change between treatments.

Analysis details and source

Endpoint means from Table 2; p value compares changes in Table 3, not raw endpoints. Missing BDI SD is printed incompletely and remains null.

18
Immediately after treatment

Mental health

SF-36 mental component Points

means
GroupnBaselineReported change
Laser plus exercise20—3.2 (SD 5.5)
ESWT plus exercise20—3.1 (SD 6.7)

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

REPORTED COMPARISON TESTp = 0.414

Laser versus ESWT

Mann–Whitney U

Source-reported improvement magnitude; no superior treatment identified.

Analysis details and source

Table 3 uses positive magnitudes for pain/depression reductions and pressure/SF-36 increases; values are not reconstructed from rounded means.

19
One month after treatment

Mental health

SF-36 mental component Points

means
GroupnBaselineFollow-up
Laser plus exercise2038.7 (SD 9.1)43 (SD 8.2)
ESWT plus exercise2043.5 (SD 12.4)45.4 (SD 7.9)

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

REPORTED COMPARISON TESTp = 0.336

Laser versus ESWT change

Mann–Whitney U test of changes

No statistically significant difference in change between treatments.

Analysis details and source

Endpoint means from Table 2; p value compares changes in Table 3, not raw endpoints. Missing BDI SD is printed incompletely and remains null.

20
One month after treatment

Mental health

SF-36 mental component Points

means
GroupnBaselineReported change
Laser plus exercise20—4.4 (SD 6.5)
ESWT plus exercise20—1.9 (SD 9.9)

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

REPORTED COMPARISON TESTp = 0.336

Laser versus ESWT

Mann–Whitney U

Source-reported improvement magnitude; no superior treatment identified.

Analysis details and source

Table 3 uses positive magnitudes for pain/depression reductions and pressure/SF-36 increases; values are not reconstructed from rounded means.

How treatment was delivered
Shockwave and exercises

BTL-5000 SWT compressor POWER: 2,000 pulses, 2.0 bar, 10–15 Hz to the two most tender trapezius/paraspinal points; three sessions 5–8 days apart. Both groups received posture, range-of-motion and stretching exercises, three sets of ten daily at home for two months. The report does not explicitly classify the device as focused or radial.

Laser comparator

Ga-As laser, 904 nm, 1.2 J/cm², 6 kHz for 30 seconds at the same two trigger points, 15 sessions over three weeks plus the same home exercises. There was no sham or exercise-only arm.

HARMS & TOLERABILITY

Adverse-event ascertainment and event counts are not reported. Authors declared no conflicts and no financial support. Ethics dates/codes differ between Methods and the closing ethics statement.

LIMITS OF THE ANALYSIS

Completer analysis excludes six randomized patients; arm-specific attrition is not reported. No placebo/exercise-only arm separates treatment effects from exercise, expectation or natural change. The one-month horizon is short and masking/allocation details are missing. Demographic sex counts/percentages in Table 1 conflict internally and with the Results narrative; Table 2 prints an incomplete ESWT post-treatment BDI SD. These are not silently corrected.

Findings checked against the full source by a separate automated reviewer.

Limitations noted by the reviewers

  • Completer analysis excludes six randomized patients; arm-specific attrition is not reported. No placebo/exercise-only arm separates treatment effects from exercise, expectation or natural change. The one-month horizon is short and masking/allocation details are missing. Demographic sex counts/percentages in Table 1 conflict internally and with the Results narrative; Table 2 prints an incomplete ESWT post-treatment BDI SD. These are not silently corrected.
Research review

Source-linked critical reading

Prospective randomized comparative study. Forty-six patients were allocated; six with missing assessments were excluded and 40 were analyzed. The random sequence, allocation concealment and assessor masking are not described.

Reading depthMaterial consulted
Technical source record

Full local PDF read; All 7 PDF pages; Introduction; Methods; Results; Tables 1–3 including reporting inconsistencies; Discussion and limitations; Ethics; funding; conflicts; references

Review statusAI-assisted draft · independent automated checkThis automated check comes before the editor’s clinical review.
Study design

Prospective randomized comparative study. Forty-six patients were allocated; six with missing assessments were excluded and 40 were analyzed. The random sequence, allocation concealment and assessor masking are not described.

Participants and setting

Patients with at least three months of neck/dorsal myofascial symptoms, diagnosed by Travell and Simons criteria, with trapezius or paraspinal trigger points; 20 analyzed per treatment. Mean age was 35.3 years. Fibromyalgia and severe cervical disc disease were excluded.

Treatment protocol

BTL-5000 SWT compressor POWER: 2,000 pulses, 2.0 bar, 10–15 Hz to the two most tender trapezius/paraspinal points; three sessions 5–8 days apart. Both groups received posture, range-of-motion and stretching exercises, three sets of ten daily at home for two months. The report does not explicitly classify the device as focused or radial.

Comparison

Ga-As laser, 904 nm, 1.2 J/cm², 6 kHz for 30 seconds at the same two trigger points, 15 sessions over three weeks plus the same home exercises. There was no sham or exercise-only arm.

What was measured

VAS pain on 0–10, algometer pressure pain threshold in kg, Beck Depression Inventory and SF-36 physical/mental components were measured before, after and one month after treatment. Table 2 gives means and SD; Table 3 reports improvement/change magnitudes and between-group tests.

Results and interpretation

At one month VAS fell from 6.8 to 3.1 with laser and 7.1 to 3.9 with ESWT. Reported improvement magnitudes were 3.7 versus 3.2 points (between-group p=.512). Pressure threshold rose to 3.7 versus 3.5 kg; BDI and physical SF-36 improved within groups, but none of the ten between-group outcome/time comparisons was significant. Mental SF-36 did not improve significantly within either group. Nonsignificance does not demonstrate equivalence.

Harms and disclosures

Adverse-event ascertainment and event counts are not reported. Authors declared no conflicts and no financial support. Ethics dates/codes differ between Methods and the closing ethics statement.

Limitations

Completer analysis excludes six randomized patients; arm-specific attrition is not reported. No placebo/exercise-only arm separates treatment effects from exercise, expectation or natural change. The one-month horizon is short and masking/allocation details are missing. Demographic sex counts/percentages in Table 1 conflict internally and with the Results narrative; Table 2 prints an incomplete ESWT post-treatment BDI SD. These are not silently corrected.

Applicability

This addresses trapezius/paraspinal MPS with shared home exercise, not generalized fibromyalgia. Fewer shockwave visits may be practical, but neither equivalent efficacy nor cost-effectiveness was tested.

What stronger evidence needs

Use concealed allocation, blinded assessment, intention-to-treat analysis, an exercise-only/sham arm, longer follow-up and explicit adverse-event recording; correct demographic and ethics reporting inconsistencies.

THE ORIGINAL SOURCE

Read the original article.

Comparison of the Efficacy of Laser and Extracorporeal Shockwave Therapy in Patients with Myofascial Pain Syndrome

Özyiğit E, Erdal A · Archives of Basic and Clinical Research · 2024

Open the publication record or available full-text files.

Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →